We make health research accessible to everyone, everywhere.

New treatments would not be possible without volunteers like you. By joining our community you will get access to clinical trials that are right for you.

Help discover cutting edge treatments

Benefit from treatments not available elsewhere

Learn about your health and medical conditions

Frequently asked questions

Please feel free to contact us with any questions you may have that we haven’t covered below.

What is a clinical trial?

A clinical trial is a medical study comparing the effect of different healthcare treatments. They are essential for finding new, safer and more effective treatments for all kinds of health conditions.

Will I be paid for participating in research?

Most trials and studies will cover your travel expenses and other expenses you may incur from participation. Some offer additional compensation. Full details of compensation can be found on the relevant study page.

Who can take part in a clinical trial or study?

Every clinical trial has unique requirements for taking part, called the ‘inclusion’ and ‘exclusion’ criteria. If you don't qualify for one trial you're interested in, you may qualify for another in your area. You can also fill out your profile here to sign up for alerts from Lindus Health when new trials match your profile.

Is it safe to take part in a clinical trial?

Yes. The safety of participants is very important. Before any clinical trial can begin, plans must be approved by medical regulators and ethics committees. All participants in clinical trials are under the care of the trial teams, who must include qualified doctors and clinicians. The care they receive must be at least as good as care received by the general population.

Can I change my mind about taking part?

Yes, you can still leave a clinical trial at any time, for any reason.

How much time does it take to participate in a trial or study?

Time commitment varies across clinical trials. Full details of time commitments are available on the study page, or you can ask the study staff.

What is a control arm or placebo?

A ‘control arm’ or ‘placebo’ is often used to fairly assess how effective a treatment is. In some clinical trials, up to half the participants may receive an existing treatment or a placebo (a dummy treatment). The results of these participants are compared against the participants who had the new treatment. This helps remove bias and fairly assess how well the new treatment works.

What do you do with my data?

We ask for your permission before collecting and storing any of your data, and sharing it with the study teams. All results are completely confidential. For full details, please see our privacy policy. Volunteers for clinical trials and studies are essential to moving healthcare forward. If you're ready to get involved, start searching for a trial that matches you today.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.

Headshot Hayley Holt

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.

Headshot Ece Kavalci

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.

Headhshot Meri Beckwith

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.

Headshot Rebbeca de Rome

Our current trials.

FLORA: Fibre maintained healthy blood sugar levels in a pre-diabetes trial (FLORA)

It has been shown that dietary fibre consumed in our every day diet can help maintain healthy blood glucose levels.

The FLORA Trial is trying to find out whether a unique powdered fibre mix helps maintain healthy blood sugar levels in people with pre-diabetes, where high blood sugar is a risk of diabetes.

The FLORA study is 24 weeks long and involves 3 in-person central clinical visits (these can be done on a weekend). The rest of the study will be conducted remotely, using a smartphone or computer.

Click here to take part

Study For

People diagnosed with pre-diabetics in the past year

Sponsored By

Myota

Participants

60

 people

Participate by

March 31, 2023

Wise Therapeutics: Social Anxiety Study

The study aims to evaluate Wise Therapeutics’ mobile game as a treatment for social anxiety (anxiety experienced in relation to social situations) in people aged 22-65 years old. The study will be conducted completely remotely. There will be a small financial compensation for completing the trial.

This study is registered on clinicaltrials.gov and co-sponsored by Hunter College of City University of New York.

Click here to take part

Study For

US-based individuals aged 22-65 years old, with symptoms of social anxiety.

Sponsored By

Wise Therapeutics & Hunter College, The City University of New York

Participants

150

 people

Participate by

December 31, 2022

CABIN study: researching new treatment for people with low mood

This study is researching how antidepressants and behavioural therapy affect people who are experiencing low mood. The study hopes to develop better personalised treatment for low mood.

The study is looking for people who are feeling low in mood but who are not currently taking any medication to treat depression or receiving any type of psychological therapy. The study will involve 6 research visits, 1 in person at the research site at the University of Oxford and 5 online. You will receive £150 for participation.

Click here to take part

Study For

Adults with low mood, who are not currently receiving any medication or therapy.

Sponsored By

University of Oxford

Participants

135

 people

Participate by

December 30, 2022

PAX-D study: treatment resistant depression

The purpose of this study is to find out if pramipexole is a useful treatment for treatment resistant depression (TRD). A significant proportion of people diagnosed with clinical depression (up to 3 in 10) do not improve with current first-line treatments and are regarded as having TRD. Current medicines for TRD are not particularly effective for many people and often have unwanted effects which may be distressing.

There is some evidence that pramipexole may be an effective treatment for TRD. Pramipexole is unlike current antidepressant drugs in that it acts like a brain chemical called dopamine, which is known to influence people’s motivation to pursue goals and affects how rewarding they find them. This study will require visits to Oxford.

Click here to take part

Study For

Adults with treatment resistant depression

Sponsored By

University of Oxford

Participants

204

 people

Participate by

December 31, 2022

APEX study: helping to understand asthma attacks

This study is investigating asthma attacks. The research team are looking for people with asthma of any severity.

You will be joining ground-breaking research into understanding asthma attacks and the information the team learns from your participation could help to discover new, potentially lifesaving treatments for asthma patients in the future. It may also help you to better understand and cope with your asthma.

You will be free to withdraw from the study at any time without your legal or medical rights being affected. The information collected during the study will be strictly confidential.

Click here to take part

Study For

Adults with asthma

Sponsored By

University of Nottingham

Participants

200

 people

Participate by

December 31, 2022

RELAKS: Study researching effects of Ketamine

This research study is looking to investigate the effects of ketamine, particularly how ketamine could affect people’s performance on decision making tasks involving learning and memory. There will be a total of 4 visits, including an infusion visit during which participants will be given either ketamine or a placebo. Research is being conducted by the University of Oxford.

You will receive £250 for taking part in the study and any reasonable travel expenses will also be covered.

Click here to take part

Study For

Healthy adults aged 18-45

Sponsored By

University of Oxford

Participants

70

 people

Participate by

December 30, 2022